PiSA USA

Executive Summary

PiSA USA, headquartered in San Diego, California, is a newly established private company in the small molecules and drug delivery sectors. Founded in 2026, the company leverages significant manufacturing and distribution capabilities in Mexico, including over 20,000 employees and 3,000,000 ft² of facilities, along with three ethylene-oxide sterilization sites in Guadalajara and Tijuana. Despite its recent founding and small corporate team of 1-10 employees, PiSA USA is positioned to serve the pharmaceutical industry with contract manufacturing and drug delivery solutions. The company's commercial organization is supported by a large operational footprint, suggesting a focus on scalable production and sterile manufacturing. As a startup, PiSA USA faces typical early-stage risks but benefits from established infrastructure in Mexico. Its success will depend on securing client contracts, regulatory approvals, and navigating supply chain dynamics. The company's ability to integrate its US headquarters with Mexican operations offers cost advantages and proximity to key markets.

Upcoming Catalysts (preview)

• Q4 2026Commercial agreement or partnership with a pharmaceutical company40% success
• TBDExpansion of manufacturing capacity or new sterilization facility30% success
• Q2 2027Regulatory milestone (e.g., FDA inspection or approval)35% success